{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:02:05Z","timestamp":1790820125723,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007658","name":"Baxter Healthcare Corporation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100007658","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gerald and Tootsie Halbert Chair in Neural Repair and Regeneration","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Frederick Banting and Charles Best Graduate Scholarship","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12974-019-1518-0","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T13:02:47Z","timestamp":1562677367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["The effects of human immunoglobulin G on enhancing tissue protection and neurobehavioral recovery after traumatic cervical spinal cord injury are mediated through the neurovascular unit"],"prefix":"10.1186","volume":"16","author":[{"given":"Jonathon Chon Teng","family":"Chio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Badner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vithushan","family":"Surendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5722-6364","authenticated-orcid":false,"given":"Michael G.","family":"Fehlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,9]]},"reference":[{"key":"1518_CR1","unstructured":"Kjell, J. & Olson, L. Rat models of spinal cord injury: from pathology to potential therapies. 9, 1125\u20131137 (2016)."},{"key":"1518_CR2","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0306-4522(97)00011-0","volume":"79","author":"Y Taoka","year":"1997","unstructured":"Taoka Y, et al. Role of neutrophils in spinal cord injury in the rat. Neuroscience. 1997;79:1177\u201382.","journal-title":"Neuroscience"},{"key":"1518_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1006\/exnr.1999.7118","volume":"158","author":"PG Popovich","year":"1999","unstructured":"Popovich PG, et al. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol. 1999;158:351\u201365. \n                    https:\/\/doi.org\/10.1006\/exnr.1999.7118\n                    \n                  .","journal-title":"Exp Neurol"},{"key":"1518_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1046\/j.1471-4159.2003.02240.x","volume":"88","author":"F Bao","year":"2004","unstructured":"Bao F, Chen Y, Dekaban GA, Weaver LC. Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J Neurochem. 2004;88:1335\u201344.","journal-title":"J Neurochem"},{"key":"1518_CR5","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1523\/jneurosci.5343-03.2004","volume":"24","author":"D Gris","year":"2004","unstructured":"Gris D, et al. Transient blockade of the CD11d\/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J Neurosci. 2004;24:4043\u201351. \n                    https:\/\/doi.org\/10.1523\/jneurosci.5343-03.2004\n                    \n                  .","journal-title":"J Neurosci"},{"key":"1518_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1089\/neu.2006.23.318","volume":"23","author":"DC Baptiste","year":"2006","unstructured":"Baptiste DC, Fehlings MG. Pharmacological approaches to repair the injured spinal cord. J Neurotrauma. 2006;23:318\u201334. \n                    https:\/\/doi.org\/10.1089\/neu.2006.23.318\n                    \n                  .","journal-title":"J Neurotrauma"},{"key":"1518_CR7","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/j.1460-9568.2007.05447.x","volume":"25","author":"T Riegger","year":"2007","unstructured":"Riegger T, et al. Spinal cord injury-induced immune depression syndrome (SCI-IDS). Eur J Neurosci. 2007;25:1743\u20137. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05447.x\n                    \n                  .","journal-title":"Eur J Neurosci"},{"issue":"3","key":"1518_CR8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/brain\/awv375","volume":"139","author":"Benedikt Brommer","year":"2016","unstructured":"Brommer B, et al. Spinal cord injury-induced immune deficiency syndrome enhances infection susceptibility dependent on lesion level. Brain: a Journal of Neurology. 2016. \n                    https:\/\/doi.org\/10.1093\/brain\/awv375\n                    \n                  .","journal-title":"Brain"},{"key":"1518_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.expneurol.2016.05.001","volume":"283","author":"Evan Z. Goldstein","year":"2016","unstructured":"Goldstein EZ, Church JS, Hesp ZC, Popovich PG, McTigue DM. A silver lining of neuroinflammation: beneficial effects on myelination. Exp Neurol. 2016. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2016.05.001\n                    \n                  .","journal-title":"Experimental Neurology"},{"key":"1518_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","volume":"26","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn F, Ravetch JV. Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol. 2008;26:513\u201333. \n                    https:\/\/doi.org\/10.1146\/annurev.immunol.26.021607.090232\n                    \n                  .","journal-title":"Annu Rev Immunol"},{"issue":"Suppl 1","key":"1518_CR11","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1007\/s10875-014-0021-8","volume":"34","author":"A Tzekou","year":"2014","unstructured":"Tzekou A, Fehlings MG. Treatment of spinal cord injury with intravenous immunoglobulin G: preliminary evidence and future perspectives. J Clin Immunol. 2014;34(Suppl 1):S132\u20138. \n                    https:\/\/doi.org\/10.1007\/s10875-014-0021-8\n                    \n                  .","journal-title":"J Clin Immunol"},{"key":"1518_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jocn.2008.04.024","volume":"16","author":"B Gok","year":"2009","unstructured":"Gok B, et al. Immunomodulation of acute experimental spinal cord injury with human immunoglobulin G. Journal of Clinical Neuroscience: official journal of the Neurosurgical Society of Australasia. 2009;16:549\u201353. \n                    https:\/\/doi.org\/10.1016\/j.jocn.2008.04.024\n                    \n                  .","journal-title":"Journal of Clinical Neuroscience: official journal of the Neurosurgical Society of Australasia"},{"issue":"7","key":"1518_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/acn3.318","volume":"3","author":"Faith H. Brennan","year":"2016","unstructured":"Brennan FH, et al. IVIg attenuates complement and improves spinal cord injury outcomes in mice. Annals of Clinical and Translational Neurology, n\/a-n\/a. 2016. \n                    https:\/\/doi.org\/10.1002\/acn3.318\n                    \n                  .","journal-title":"Annals of Clinical and Translational Neurology"},{"key":"1518_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/cne.10736","volume":"462","author":"JM Sroga","year":"2003","unstructured":"Sroga JM, Jones TB, Kigerl KA, McGaughy VM, Popovich PG. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol. 2003;462:223\u201340. \n                    https:\/\/doi.org\/10.1002\/cne.10736\n                    \n                  .","journal-title":"J Comp Neurol"},{"key":"1518_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-224","volume":"9","author":"DH Nguyen","year":"2012","unstructured":"Nguyen DH, et al. Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury. J Neuroinflammation. 2012;9:224. \n                    https:\/\/doi.org\/10.1186\/1742-2094-9-224\n                    \n                  .","journal-title":"J Neuroinflammation"},{"key":"1518_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3171\/jns.1977.47.4.0577","volume":"47","author":"AS Rivlin","year":"1977","unstructured":"Rivlin AS, Tator CH. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg. 1977;47:577\u201381. \n                    https:\/\/doi.org\/10.3171\/jns.1977.47.4.0577\n                    \n                  .","journal-title":"J Neurosurg"},{"key":"1518_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/0014-4886(95)90027-6","volume":"132","author":"MG Fehlings","year":"1995","unstructured":"Fehlings MG, Tator CH. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol. 1995;132:220\u20138.","journal-title":"Exp Neurol"},{"key":"1518_CR18","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1001\/jama.1997.03540440031029","volume":"277","author":"MB Bracken","year":"1997","unstructured":"Bracken MB, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. Jama. 1997;277:1597\u2013604.","journal-title":"Jama"},{"key":"1518_CR19","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1089\/neu.2013.3319","volume":"31","author":"M Soubeyrand","year":"2014","unstructured":"Soubeyrand M, Badner A, Vawda R, Chung YS, Fehlings MG. Very high resolution ultrasound imaging for real-time quantitative visualization of vascular disruption after spinal cord injury. J Neurotrauma. 2014;31:1767\u201375. \n                    https:\/\/doi.org\/10.1089\/neu.2013.3319\n                    \n                  .","journal-title":"J Neurotrauma"},{"key":"1518_CR20","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.5966\/sctm.2014-0029","volume":"3","author":"JT Wilcox","year":"2014","unstructured":"Wilcox JT, Satkunendrarajah K, Zuccato JA, Nassiri F, Fehlings MG. Neural precursor cell transplantation enhances functional recovery and reduces astrogliosis in bilateral compressive\/contusive cervical spinal cord injury. Stem Cells Transl Med. 2014;3:1148\u201359. \n                    https:\/\/doi.org\/10.5966\/sctm.2014-0029\n                    \n                  .","journal-title":"Stem Cells Transl Med"},{"key":"1518_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2007.10.099","volume":"1189","author":"A Zozulya","year":"2008","unstructured":"Zozulya A, Weidenfeller C, Galla HJ. Pericyte-endothelial cell interaction increases MMP-9 secretion at the blood-brain barrier in vitro. Brain Res. 2008;1189:1\u201311. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2007.10.099\n                    \n                  .","journal-title":"Brain Res"},{"key":"1518_CR22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.expneurol.2007.06.009","volume":"209","author":"DJ Donnelly","year":"2008","unstructured":"Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol. 2008;209:378\u201388. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2007.06.009\n                    \n                  .","journal-title":"Exp Neurol"},{"key":"1518_CR23","first-page":"1012","volume":"9","author":"Z He","year":"2017","unstructured":"He Z, et al. Inhibiting endoplasmic reticulum stress by lithium chloride contributes to the integrity of blood-spinal cord barrier and functional recovery after spinal cord injury. Am J Transl Res. 2017;9:1012\u201324.","journal-title":"Am J Transl Res"},{"key":"1518_CR24","doi-asserted-by":"publisher","first-page":"7526","DOI":"10.1523\/JNEUROSCI.22-17-07526.2002","volume":"22","author":"LJ Noble","year":"2002","unstructured":"Noble LJ, Donovan F, Igarashi T, Goussev S, Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci. 2002;22:7526\u201335.","journal-title":"J Neurosci"},{"key":"1518_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/10409238.2013.770819","volume":"48","author":"J Vandooren","year":"2013","unstructured":"Vandooren J, Van den Steen PE, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade. Crit Rev Biochem Mol Biol. 2013;48:222\u201372. \n                    https:\/\/doi.org\/10.3109\/10409238.2013.770819\n                    \n                  .","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"1518_CR26","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1097\/00001756-200011090-00029","volume":"11","author":"RC de Castro Jr","year":"2000","unstructured":"de Castro RC Jr, Burns CL, McAdoo DJ, Romanic AM. Metalloproteinase increases in the injured rat spinal cord. Neuroreport. 2000;11:3551\u20134.","journal-title":"Neuroreport"},{"key":"1518_CR27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1523\/jneurosci.4918-08.2009","volume":"29","author":"DP Stirling","year":"2009","unstructured":"Stirling DP, Liu S, Kubes P, Yong VW. Depletion of Ly6G\/gr-1 leukocytes after spinal cord injury in mice alters wound healing and worsens neurological outcome. J Neurosci. 2009;29:753\u201364. \n                    https:\/\/doi.org\/10.1523\/jneurosci.4918-08.2009\n                    \n                  .","journal-title":"J Neurosci"},{"key":"1518_CR28","doi-asserted-by":"publisher","first-page":"12970","DOI":"10.1523\/jneurosci.1974-13.2013","volume":"33","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, et al. Autonomic dysreflexia causes chronic immune suppression after spinal cord injury. J Neurosci. 2013;33:12970\u201381. \n                    https:\/\/doi.org\/10.1523\/jneurosci.1974-13.2013\n                    \n                  .","journal-title":"J Neurosci"},{"key":"1518_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00401-014-1355-2","volume":"129","author":"J Neumann","year":"2015","unstructured":"Neumann J, et al. Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke. Acta Neuropathol. 2015;129:259\u201377. \n                    https:\/\/doi.org\/10.1007\/s00401-014-1355-2\n                    \n                  .","journal-title":"Acta Neuropathol"},{"key":"1518_CR30","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1038\/jcbfm.2013.160","volume":"33","author":"I St-Amour","year":"2013","unstructured":"St-Amour I, et al. Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier. Journal of Cerebral Blood Flow and Metabolism: official Journal of the International Society of Cerebral Blood Flow and Metabolism. 2013;33:1983\u201392. \n                    https:\/\/doi.org\/10.1038\/jcbfm.2013.160\n                    \n                  .","journal-title":"Journal of Cerebral Blood Flow and Metabolism: official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"1518_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep40528","volume":"7","author":"M Chen","year":"2017","unstructured":"Chen M, et al. Disease-modifying effect of intravenous immunoglobulin in an experimental model of epilepsy. Sci Rep. 2017;7:40528. \n                    https:\/\/doi.org\/10.1038\/srep40528\n                    \n                  .","journal-title":"Sci Rep"},{"key":"1518_CR32","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jaci.2013.09.029","volume":"133","author":"AH Massoud","year":"2014","unstructured":"Massoud AH, et al. Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells. J Allergy Clin Immunol. 2014;133:853\u2013863.e855. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2013.09.029\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"key":"1518_CR33","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1073\/pnas.0807319106","volume":"106","author":"B Tackenberg","year":"2009","unstructured":"Tackenberg B, et al. Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy. Proc Natl Acad Sci U S A. 2009;106:4788\u201392. \n                    https:\/\/doi.org\/10.1073\/pnas.0807319106\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1518_CR34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood-2003-01-0023","volume":"102","author":"AR Crow","year":"2003","unstructured":"Crow AR, et al. IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity. Blood. 2003;102:558\u201360. \n                    https:\/\/doi.org\/10.1182\/blood-2003-01-0023\n                    \n                  .","journal-title":"Blood"},{"key":"1518_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-106","volume":"8","author":"F Takata","year":"2011","unstructured":"Takata F, et al. Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-alpha, releasing matrix metalloproteinase-9 and migrating in vitro. J Neuroinflammation. 2011;8:106. \n                    https:\/\/doi.org\/10.1186\/1742-2094-8-106\n                    \n                  .","journal-title":"J Neuroinflammation"},{"key":"1518_CR36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1126\/science.1203165","volume":"333","author":"C Goritz","year":"2011","unstructured":"Goritz C, et al. A pericyte origin of spinal cord scar tissue. Science (New York, NY). 2011;333:238\u201342. \n                    https:\/\/doi.org\/10.1126\/science.1203165\n                    \n                  .","journal-title":"Science (New York, NY)"},{"key":"1518_CR37","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik A, et al. Pericytes regulate the blood-brain barrier. Nature. 2010;468:557\u201361. \n                    https:\/\/doi.org\/10.1038\/nature09522\n                    \n                  .","journal-title":"Nature"},{"key":"1518_CR38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1089\/neu.2013.3034","volume":"31","author":"SA Figley","year":"2014","unstructured":"Figley SA, Khosravi R, Legasto JM, Tseng YF, Fehlings MG. Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury. J Neurotrauma. 2014;31:541\u201352. \n                    https:\/\/doi.org\/10.1089\/neu.2013.3034\n                    \n                  .","journal-title":"J Neurotrauma"},{"key":"1518_CR39","doi-asserted-by":"publisher","first-page":"991","DOI":"10.5966\/sctm.2015-0295","volume":"5","author":"A Badner","year":"2016","unstructured":"Badner A, et al. Early intravenous delivery of human brain stromal cells modulates systemic inflammation and leads to vasoprotection in traumatic spinal cord injury. Stem Cells Transl Med. 2016;5:991\u20131003. \n                    https:\/\/doi.org\/10.5966\/sctm.2015-0295\n                    \n                  .","journal-title":"Stem Cells Transl Med"},{"key":"1518_CR40","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1089\/neu.2014.3429","volume":"31","author":"AL Bowes","year":"2014","unstructured":"Bowes AL, Yip PK. Modulating inflammatory cell responses to spinal cord injury: all in good time. J Neurotrauma. 2014;31:1753\u201366. \n                    https:\/\/doi.org\/10.1089\/neu.2014.3429\n                    \n                  .","journal-title":"J Neurotrauma"},{"key":"1518_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3171\/spi.2006.5.4.343","volume":"5","author":"DS Ditor","year":"2006","unstructured":"Ditor DS, Bao F, Chen Y, Dekaban GA, Weaver LC. A therapeutic time window for anti-CD 11d monoclonal antibody treatment yielding reduced secondary tissue damage and enhanced behavioral recovery following severe spinal cord injury. Journal of Neurosurgery Spine. 2006;5:343\u201352. \n                    https:\/\/doi.org\/10.3171\/spi.2006.5.4.343\n                    \n                  .","journal-title":"Journal of Neurosurgery Spine"},{"key":"1518_CR42","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1089\/neu.2011.2190","volume":"29","author":"F Bao","year":"2012","unstructured":"Bao F, Omana V, Brown A, Weaver LC. The systemic inflammatory response after spinal cord injury in the rat is decreased by alpha4beta1 integrin blockade. J Neurotrauma. 2012;29:1626\u201337. \n                    https:\/\/doi.org\/10.1089\/neu.2011.2190\n                    \n                  .","journal-title":"J Neurotrauma"},{"key":"1518_CR43","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.expneurol.2011.07.001","volume":"231","author":"F Bao","year":"2011","unstructured":"Bao F, Brown A, Dekaban GA, Omana V, Weaver LC. CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury. Exp Neurol. 2011;231:272\u201383. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2011.07.001\n                    \n                  .","journal-title":"Exp Neurol"},{"key":"1518_CR44","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1212\/WNL.59.12_suppl_6.S13","volume":"59","author":"MC Dalakas","year":"2002","unstructured":"Dalakas MC. Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies. Neurology. 2002;59:S13\u201321.","journal-title":"Neurology"},{"key":"1518_CR45","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/brain\/awr008","volume":"134","author":"A Liesz","year":"2011","unstructured":"Liesz A, et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain: a Journal of Neurology. 2011;134:704\u201320. \n                    https:\/\/doi.org\/10.1093\/brain\/awr008\n                    \n                  .","journal-title":"Brain: a Journal of Neurology"},{"key":"1518_CR46","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3109\/08916931003599062","volume":"43","author":"HF Macmillan","year":"2010","unstructured":"Macmillan HF, Rowter D, Lee T, Issekutz AC. Intravenous immunoglobulin G selectively inhibits IL-1alpha-induced neutrophil-endothelial cell adhesion. Autoimmunity. 2010;43:619\u201327. \n                    https:\/\/doi.org\/10.3109\/08916931003599062\n                    \n                  .","journal-title":"Autoimmunity"},{"key":"1518_CR47","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1161\/circulationaha.105.546150","volume":"112","author":"V Gill","year":"2005","unstructured":"Gill V, Doig C, Knight D, Love E, Kubes P. Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin. Circulation. 2005;112:2031\u20139. \n                    https:\/\/doi.org\/10.1161\/circulationaha.105.546150\n                    \n                  .","journal-title":"Circulation"},{"key":"1518_CR48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jconrel.2015.08.060","volume":"219","author":"Shushi Kabu","year":"2015","unstructured":"Kabu S, Gao Y, Kwon BK, Labhasetwar V. Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury. Journal of Controlled Release: official Journal of the Controlled Release Society. 2015. \n                    https:\/\/doi.org\/10.1016\/j.jconrel.2015.08.060\n                    \n                  .","journal-title":"Journal of Controlled Release"},{"key":"1518_CR49","doi-asserted-by":"publisher","first-page":"792","DOI":"10.4049\/jimmunol.1301554","volume":"192","author":"HM Trist","year":"2014","unstructured":"Trist HM, et al. Polymorphisms and interspecies differences of the activating and inhibitory FcgammaRII of Macaca nemestrina influence the binding of human IgG subclasses. Journal of Immunology (Baltimore, Md: 1950). 2014;192:792\u2013803. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1301554\n                    \n                  .","journal-title":"Journal of Immunology (Baltimore, Md: 1950)"},{"key":"1518_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00197","volume":"6","author":"AS Tjon","year":"2015","unstructured":"Tjon AS, van Gent R, Geijtenbeek TB, Kwekkeboom J. Differences in anti-inflammatory actions of intravenous immunoglobulin between mice and men: more than meets the eye. Front Immunol. 2015;6:197. \n                    https:\/\/doi.org\/10.3389\/fimmu.2015.00197\n                    \n                  .","journal-title":"Front Immunol"},{"key":"1518_CR51","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3389\/fimmu.2018.01299","volume":"9","author":"Y Guo","year":"2018","unstructured":"Guo Y, Tian X, Wang X, Xiao Z. Adverse effects of immunoglobulin therapy. Front Immunol. 2018;9:1299. \n                    https:\/\/doi.org\/10.3389\/fimmu.2018.01299\n                    \n                  .","journal-title":"Front Immunol"},{"key":"1518_CR52","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.clim.2011.08.003","volume":"141","author":"AC Issekutz","year":"2011","unstructured":"Issekutz AC, Rowter D, Macmillan HF. Intravenous immunoglobulin G (IVIG) inhibits IL-1- and TNF-alpha-dependent, but not chemotactic-factor-stimulated, neutrophil transendothelial migration. Clinical Immunology (Orlando, Fla). 2011;141:187\u201396. \n                    https:\/\/doi.org\/10.1016\/j.clim.2011.08.003\n                    \n                  .","journal-title":"Clinical Immunology (Orlando, Fla)"},{"key":"1518_CR53","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1177\/0748233712464807","volume":"30","author":"Y Morimoto","year":"2014","unstructured":"Morimoto Y, et al. Expression of cytokine-induced neutrophil chemoattractant in rat lungs following an intratracheal instillation of micron-sized nickel oxide nanoparticle agglomerates. Toxicol Ind Health. 2014;30:851\u201360. \n                    https:\/\/doi.org\/10.1177\/0748233712464807\n                    \n                  .","journal-title":"Toxicol Ind Health"},{"key":"1518_CR54","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/jnr.22343","volume":"88","author":"S Chakraborty","year":"2010","unstructured":"Chakraborty S, Kaushik DK, Gupta M, Basu A. Inflammasome signaling at the heart of central nervous system pathology. J Neurosci Res. 2010;88:1615\u201331. \n                    https:\/\/doi.org\/10.1002\/jnr.22343\n                    \n                  .","journal-title":"J Neurosci Res"},{"key":"1518_CR55","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jaci.2010.10.030","volume":"127","author":"M Ballow","year":"2011","unstructured":"Ballow M. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol. 2011;127:315\u201323; quiz 324-315. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2010.10.030\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"key":"1518_CR56","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1089\/neu.2012.2651","volume":"30","author":"CD Thompson","year":"2013","unstructured":"Thompson CD, Zurko JC, Hanna BF, Hellenbrand DJ, Hanna A. The therapeutic role of interleukin-10 after spinal cord injury. J Neurotrauma. 2013;30:1311\u201324. \n                    https:\/\/doi.org\/10.1089\/neu.2012.2651\n                    \n                  .","journal-title":"J Neurotrauma"},{"key":"1518_CR57","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/j.1471-4159.2009.05899.x","volume":"108","author":"T Genovese","year":"2009","unstructured":"Genovese T, et al. Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. J Neurochem. 2009;108:1360\u201372. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2009.05899.x\n                    \n                  .","journal-title":"J Neurochem"},{"key":"1518_CR58","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.neuroscience.2004.01.004","volume":"124","author":"KE Abraham","year":"2004","unstructured":"Abraham KE, McMillen D, Brewer KL. The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse. Neuroscience. 2004;124:945\u201352. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2004.01.004\n                    \n                  .","journal-title":"Neuroscience"},{"key":"1518_CR59","doi-asserted-by":"publisher","unstructured":"Badner A, Vidal PM, Hong J, Hacker J, Fehlings MG. Endogenous Interleukin-10 deficiency exacerbates vascular pathology in traumatic cervical spinal cord injury. J Neurotrauma. 2019. \n                    https:\/\/doi.org\/10.1089\/neu.2018.6081\n                    \n                  .","DOI":"10.1089\/neu.2018.6081"},{"key":"1518_CR60","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/j.1471-4159.2009.06253.x","volume":"110","author":"A Lyons","year":"2009","unstructured":"Lyons A, et al. Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro. J Neurochem. 2009;110:1547\u201356. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06253.x\n                    \n                  .","journal-title":"J Neurochem"},{"key":"1518_CR61","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1074\/jbc.M110.169839","volume":"286","author":"M Noda","year":"2011","unstructured":"Noda M, et al. Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression. J Biol Chem. 2011;286:2308\u201319. \n                    https:\/\/doi.org\/10.1074\/jbc.M110.169839\n                    \n                  .","journal-title":"J Biol Chem"},{"key":"1518_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00129","volume":"8","author":"RC Paolicelli","year":"2014","unstructured":"Paolicelli RC, Bisht K, Tremblay ME. Fractalkine regulation of microglial physiology and consequences on the brain and behavior. Front Cell Neurosci. 2014;8:129. \n                    https:\/\/doi.org\/10.3389\/fncel.2014.00129\n                    \n                  .","journal-title":"Front Cell Neurosci"},{"key":"1518_CR63","first-page":"89","volume":"61","author":"R Yano","year":"2007","unstructured":"Yano R, et al. Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients. Acta Med Okayama. 2007;61:89\u201398.","journal-title":"Acta Med Okayama"},{"key":"1518_CR64","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1365-2249.2009.04022.x","volume":"158","author":"A. Durandy","year":"2009","unstructured":"Durandy A, et al. Intravenous immunoglobulins--understanding properties and mechanisms. Clin Exp Immunol. 2009;158 Suppl 1, 2-13. \n                    https:\/\/doi.org\/10.1111\/j.1365-2249.2009.04022.x\n                    \n                  .","journal-title":"Clinical & Experimental Immunology"},{"key":"1518_CR65","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jdermsci.2012.09.010","volume":"69","author":"H Kudo","year":"2013","unstructured":"Kudo H, et al. Intravenous immunoglobulin treatment recovers the down-regulated levels of Th1 cytokines in the sera and skin of scleroderma patients. J Dermatol Sci. 2013;69:77\u201380. \n                    https:\/\/doi.org\/10.1016\/j.jdermsci.2012.09.010\n                    \n                  .","journal-title":"J Dermatol Sci"},{"key":"1518_CR66","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1399-3038.2008.00779.x","volume":"20","author":"HC Kuo","year":"2009","unstructured":"Kuo HC, et al. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology. 2009;20:266\u201372. \n                    https:\/\/doi.org\/10.1111\/j.1399-3038.2008.00779.x\n                    \n                  .","journal-title":"Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology"},{"key":"1518_CR67","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1046\/j.1365-2567.2002.01545.x","volume":"107","author":"WA Sewell","year":"2002","unstructured":"Sewell WA, Jolles S. Immunomodulatory action of intravenous immunoglobulin. Immunology. 2002;107:387\u201393.","journal-title":"Immunology"},{"key":"1518_CR68","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/01.ana.0000163199.10365.38","volume":"17","author":"ES Fu","year":"2005","unstructured":"Fu ES, Saporta S. Methylprednisolone inhibits production of interleukin-1beta and interleukin-6 in the spinal cord following compression injury in rats. J Neurosurg Anesthesiol. 2005;17:82\u20135.","journal-title":"J Neurosurg Anesthesiol"},{"key":"1518_CR69","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.neuroscience.2008.08.021","volume":"158","author":"T Riegger","year":"2009","unstructured":"Riegger T, et al. Immune depression syndrome following human spinal cord injury (SCI): a pilot study. Neuroscience. 2009;158:1194\u20139. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2008.08.021\n                    \n                  .","journal-title":"Neuroscience"},{"key":"1518_CR70","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/eji.201242398","volume":"42","author":"A Matsuda","year":"2012","unstructured":"Matsuda A, et al. Anti-inflammatory effects of high-dose IgG on TNF-alpha-activated human coronary artery endothelial cells. Eur J Immunol. 2012;42:2121\u201331. \n                    https:\/\/doi.org\/10.1002\/eji.201242398\n                    \n                  .","journal-title":"Eur J Immunol"},{"issue":"Suppl 1","key":"1518_CR71","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10875-016-0249-6","volume":"36","author":"F Nimmerjahn","year":"2016","unstructured":"Nimmerjahn F. Translating inhibitory fc receptor biology into novel therapeutic approaches. J Clin Immunol. 2016;36(Suppl 1):83\u20137. \n                    https:\/\/doi.org\/10.1007\/s10875-016-0249-6\n                    \n                  .","journal-title":"J Clin Immunol"},{"issue":"6","key":"1518_CR72","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/nn.4289","volume":"19","author":"Masaki Ueno","year":"2016","unstructured":"Ueno M, Ueno-Nakamura Y, Niehaus J, Popovich PG, Yoshida Y. Silencing spinal interneurons inhibits immune suppressive autonomic reflexes caused by spinal cord injury. Nat Neurosci. 2016. \n                    https:\/\/doi.org\/10.1038\/nn.4289\n                    \n                  .","journal-title":"Nature Neuroscience"},{"issue":"6","key":"1518_CR73","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1089\/neu.2016.4498","volume":"34","author":"Antigona Ulndreaj","year":"2017","unstructured":"Ulndreaj A, et al. Characterization of the antibody response after cervical spinal cord injury. J Neurotrauma. 2016. \n                    https:\/\/doi.org\/10.1089\/neu.2016.4498\n                    \n                  .","journal-title":"Journal of Neurotrauma"},{"key":"1518_CR74","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1126\/science.1175202","volume":"325","author":"FK Swirski","year":"2009","unstructured":"Swirski FK, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (New York, NY). 2009;325:612\u20136. \n                    https:\/\/doi.org\/10.1126\/science.1175202\n                    \n                  .","journal-title":"Science (New York, NY)"},{"key":"1518_CR75","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.neuropharm.2014.06.004","volume":"85","author":"P Cheng","year":"2014","unstructured":"Cheng P, Kuang F, Zhang H, Ju G, Wang J. Beneficial effects of thymosin beta4 on spinal cord injury in the rat. Neuropharmacology. 2014;85:408\u201316. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2014.06.004\n                    \n                  .","journal-title":"Neuropharmacology"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1518-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-019-1518-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1518-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T23:11:48Z","timestamp":1594163508000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-019-1518-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,9]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1518"],"URL":"https:\/\/doi.org\/10.1186\/s12974-019-1518-0","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,9]]},"assertion":[{"value":"27 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the animal care committee at the University Health Network (Toronto, Ontario, Canada) in compliance with the Canadian Council on Animal Care.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}